ArticleClinical and experimental immunology2022

SR-A neutralizing antibody: potential drug candidate for ameliorating osteoclastogenesis in rheumatoid arthritis.

Yang Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.